SCHEMBL7534587

SCHEMBL7534587

O=C(O)c1ccc(N=c2[nH]c(=Nc3ccc(C(=O)O)cc3)[nH]c(=Nc3ccc(C(=O)O)cc3)[nH]2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.52
▸ TP53 P04637 1/20 0.52
▸ TRPA1 O75762 1/20 0.52
▸ CA2 P00918 5/20 0.50
▸ CA1 P00915 4/20 0.50
▸ CA12 O43570 2/20 0.50
▸ CA9 Q16790 2/20 0.50
▸ MAOA P21397 1/20 0.50
▸ MAOB P27338 1/20 0.50
▸ SRD5A2 P31213 1/20 0.46
▸ CA3 P07451 1/20 0.44
▸ TYR P14679 1/20 0.44
▸ DRD1 P21728 1/20 0.44
▸ CA4 P22748 1/20 0.44
▸ CA6 P23280 1/20 0.44
▸ CA5A P35218 1/20 0.44
▸ CA7 P43166 1/20 0.44
▸ CA14 Q9ULX7 1/20 0.44
▸ CA5B Q9Y2D0 1/20 0.44
▸ MEN1 O00255 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11459536 0.78 MAPT (0.40) TSHRTP53CA2CA1CA12
Terephthalic Acid SCHEMBL5969822 0.75 TSHR (0.92) TSHRTP53CA2CA1CA12
SCHEMBL31702246 0.74 TRPA1 (0.86) TSHRTP53TRPA1CA2CA1
SCHEMBL3364649 0.74 TRPA1 (0.86) TSHRTP53TRPA1CA2CA1
SCHEMBL9865481 0.74 TSHR (0.67) TSHRTP53TRPA1CA2CA1
SCHEMBL70163 0.74 TRPA1 (0.86) TSHRTP53TRPA1CA2CA1
SCHEMBL70162 0.74 TRPA1 (0.86) TSHRTP53TRPA1CA2CA1
Terephthalic Acid SCHEMBL2511919 0.72 TSHR (1.00) TSHRTP53CA2CA1CA12
Terephthalic Acid SCHEMBL5053781 0.72 TSHR (1.00) TSHRTP53CA2CA1CA12
Terephthalic Acid SCHEMBL175823 0.72 TSHR (1.00) TSHRTP53CA2CA1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3388048-B1 SUNSCREEN WITH A REDUCED TENDENCY TO STAIN TEXTILES III BEIERSDORF AG (DE) 2020-08-26 — — EP claimed
EP-1076552-B1 COSMETIC AND DERMATOLOGICAL LIGHT-PROTECTIVE FORMULATIONS CONTAINING TRIAZINE DERIVATIVES AND ONE OR SEVERAL ESTERS OF UNBRANCHED-CHAIN CARBOXYLIC ACIDS AND BRANCHED-CHAIN ALCOHOLS BEIERSDORF AG (DE) 2002-07-17 — — EP claimed
EP-0876136-B1 STABLE COSMETIC AND DERMATOLOGICAL LIGHT-PROTECTING PREPARATIONS IN THE FORM OF WATER/OIL EMULSIONS CONTAINING INORGANIC MICRO-PIGMENTS, DERIVATIVES OF TRIAZINE AND/OR OTHER COMPONENTS BEIERSDORF AG (DE) 2002-05-08 — — EP claimed
EP-4167938-A1 BIODEGRADABLE UV ABSORBERS BASF SE (DE) 2023-04-26 — — EP disclosed
EP-4117617-A1 ANTI-AGING CARE COMPOSITION COMPRISING PERFUMES BASF SE (DE) 2023-01-18 — — EP disclosed
EP-3937896-A1 SUNSCREEN COMPOSITIONS COMPRISING BUTYL METHOXYDIBENZOYLMETHANE, TRIAZINE DERIVATIVES AND PHOTOSTABILIZER BASF SE (DE) 2022-01-19 — — EP disclosed
WO-2021254998-A1 BIODEGRADABLE UV ABSORBERS BASF SE (DE) 2021-12-23 — — WO disclosed
WO-2021180839-A1 ANTI-AGING CARE COMPOSITION COMPRISING PERFUMES BASF SE (DE) 2021-09-16 — — WO disclosed
US-11078219-B2 Method for producing coordinatively unsaturated metal-organic framework and coordinatively unsaturated metal-organic framework TOYOTA JIDOSHA KABUSHIKI KAISHA 2021-08-03 — — US disclosed
WO-2020187773-A1 SUNSCREEN COMPOSITIONS COMPRISING BUTYL METHOXYDIBENZOYLMETHANE, TRIAZINE DERIVATIVES AND PHOTOSTABILIZER BASF SE (DE) 2020-09-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11078219-B2 Method for producing coordinatively unsaturated metal-organic framework and coordinatively unsaturated metal-organic framework TRPM8, F8, SLC16A8 TSHR 3038/4885TP53 2466/4885TRPA1 180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback